Patient-specific blood–brain tumor barrier chip predicts glioblastoma treatment responses
Glioblastoma is one of the most aggressive and difficult-to-treat brain cancers, yet its response to therapy can vary dramatically from...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Glioblastoma is one of the most aggressive and difficult-to-treat brain cancers, yet its response to therapy can vary dramatically from...
A small but important subset of ovarian cancers long regarded as resistant to both chemotherapy and immunotherapy may contain an...
A daily sugar-sweetened beverage may be doing more than adding calories to the diet: it may also be linked to...
A new study of nearly 13 million U.S. death certificates has identified flight attendants and pilots as the occupations with...
Cancer researchers have unveiled a standardized pathology and molecular workflow designed to solve one of the most difficult problems in...
Cervical cancer may need more than a single therapeutic strategy, according to a new study that combines large-scale gene-expression analysis...
A metabolic enzyme best known for helping cells build the genetic material needed for growth has emerged as a potential...
Pancreatic cancer has acquired another layer of biological complexity, according to a new study identifying a molecular pathway that may...
Colorectal cancer is often treatable when detected early, yet its danger changes dramatically once malignant cells escape the intestine and...
Advanced gastric and gastroesophageal junction cancers are receiving renewed attention after researchers reported a clinical study testing a three-part first-line...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine